Stratification of Patients using advanced Integrative modelling of Data Routinely acquired for diagnosing Rheumatic complaints

使用常规获取的用于诊断风湿病症状的先进数据综合模型对患者进行分层

• 批准号: 10066059
• 金额: $ 50.65万
• 依托单位: NEWCASTLE UNIVERSITY
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10066059
• 关键词: Stratification; Patients; using; advanced; Integrative

Globally 1.71 billion people have musculoskeletal symptoms, the leading contributor to disability. Early disease stratification is important to ensure appropriate care (most suited healthcare provider and best treatment choice). Currently the patient journey to diagnosis and effective treatment is long and inefficient, resulting in persistent disease burden and economic loss. This is due to insufficiently understood disease causes, similarities in symptoms between diseases, insufficiently discriminatory diagnostic tests and a “ trial and error” approach in initial treatment. SPIDeRR aims to disentangle the real-life complexity of early diagnosis of rheumatic diseases by considering the complete web of factors influencing patients’ symptoms. SPIDeRR’s approach will go well beyond the state-of-the-art in the following ways: -By identifying different disease groups, requiring different therapies, amongst patients with similar symptoms in contrast to the traditional approach aiming to only capture one disease early. -?By integrating all relevant data dimensions from every healthcare level (primary and secondary care and patients seeking advice online). -?By translating and applying machine learning techniques from the “omics” field to clinical patient data, which will result in new pipelines for translational data science SPIDERR will deliver three clinical models -a symptom checker for patients -a decision support tool for (primary) care providers providing guiding additional examination and referral decisions -a patient-patient similarity network to optimise diagnostic groups in rheumatology and support treatment decision To achieve this we additionally deliver solutions for data integration and shared analyses though GDPR compliant digital research environment and federated learning pipelines. Finally we will test the acceptability of the models through stakeholders studies and provide an implementation scene tailored to current healthcare in Europe.

全球有17.1亿人患有肌肉骨骼症状，这是导致残疾的主要因素。早期疾病分层对于确保适当的护理（最合适的医疗保健提供者和最佳治疗选择）非常重要。目前，患者到诊断和有效治疗的旅程漫长且效率低下，导致持续的疾病负担和经济损失。这是由于对疾病原因了解不够，疾病之间症状相似，诊断测试不充分，以及初始治疗中的“试错”方法。SPIDeRR旨在通过考虑影响患者症状的完整因素网络来解开风湿性疾病早期诊断的现实复杂性。SPIDeRR的方法将在以下方面远远超出最先进的水平：-通过识别不同的疾病组，需要不同的治疗方法，在具有相似症状的患者中，与传统方法相比，传统方法旨在早期仅捕获一种疾病。-?通过整合来自每个医疗保健水平的所有相关数据维度（初级和二级护理以及在线寻求建议的患者）。-?通过将机器学习技术从“组学”领域转化并应用于临床患者数据，SPIDERR将提供三种临床模型--患者症状检查器--为（初级）保健提供者提供指导性额外检查和转诊决策的决策支持工具--患者--为了实现这一目标，我们还通过符合GDPR的数字研究环境和联合学习管道提供数据集成和共享分析解决方案。最后，我们将通过利益相关者的研究来测试模型的可接受性，并提供一个适合欧洲当前医疗保健的实施场景。